Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study.

Jerkeman, M; Anderson, H; Dictor, M; Kvaløy, S; Akerman, M; Cavallin-Ståhl, E

Jerkeman, M; Anderson, H; Dictor, M; Kvaløy, S; Akerman, M; Cavallin-Ståhl, E.

Affiliation

Jerkeman M; Department of Oncology, Jubileum Institute, Lund University Hospital, Sweden. mats.jerkeman@onk.lu.se

Ann Hematol ; 83(7): 414-9, 2004 Jul.

Article de En | MEDLINE | ID: mdl-15085385

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphome B diffus à grandes cellules / Protéines tumorales Type d'étude: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Pays/Région comme sujet: Europa Langue: En Journal: Ann Hematol Sujet du journal: HEMATOLOGIA Année: 2004 Type de document: Article Pays d'affiliation: Suède

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links